Loading...
Market
How many countries will adopt heparin as a standard treatment for snake bites by end of 2025?
2
Resolution / Starting Odds
1-2 countries • 25%
3-5 countries • 25%
6-10 countries • 25%
More than 10 countries • 25%
Official health policy updates from national health departments
Story
Common Blood Thinner Heparin Found to Neutralize Cobra Venom and Flesh-Eating Snake Bites
Jul 17, 2024, 08:23 PM
A global study suggests that the common blood thinner heparin could be repurposed as an antidote to cobra venom. Researchers from Australia, Canada, Costa Rica, and the UK, including Sydney scientists, have discovered that heparin can neutralize the venom, potentially revolutionizing the treatment of cobra bites and flesh-eating snake bites. This development could drastically reduce the terrible injuries caused by cobra bites and improve survival rates, preventing thousands of deaths. The study indicates that heparin may also prevent snakebite victims from losing limbs, offering a cheap and effective solution to a significant medical issue.
View original story
Similar markets
0 • 25%
1-2 • 25%
3-4 • 25%
5 or more • 25%
United States • 25%
European Union • 25%
Asia • 25%
Other • 25%
Yes • 50%
No • 50%
American Medical Association (AMA) • 25%
World Health Organization (WHO) • 25%
Centers for Disease Control and Prevention (CDC) • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
0-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%
Less than 20 countries • 25%
20 to 40 countries • 25%
41 to 60 countries • 25%
More than 60 countries • 25%
Public awareness campaigns • 25%
Improved medical treatment access • 25%
Increased antivenom distribution • 25%
Other • 25%
0-10 countries • 25%
11-20 countries • 25%
21-30 countries • 25%
31+ countries • 25%
1-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%